What are the main purchasing channels for Apelix-Piqray?

Alpelisib (Alpelisib)-Piqray, as the world's first approved oral breast cancer drug targeting PIK3CA mutations, accurately matches its treatment mechanism with the target population, making it rapidly widely used in European and American markets. However, as of now, Apelis has not yet been launched as the original drug in mainland China, which means that patients cannot obtain the drug directly through domestic hospitals or medical insurance channels, and it has not been included in the national medical insurance directory.

Although the original drug has not been launched in China, Apelvis has been officially sold in many European countries and India, and has a stable drug supply system. The European version is usually supplied directly by Novartis, has strict quality standards, and is suitable for patients who can afford the high cost themselves. The Indian version is copied by authorized pharmaceutical companies in accordance with international standards. Although the price is relatively low, it is also recognized by the international medical community and has become a viable choice for many patients.

In addition, generic versions have also appeared in some Southeast Asian countries such as Laos, which are mainly synthesized by local pharmaceutical companies based on original ingredients. Although they may not have a complete international registration process, due to their price advantages and high consistency of generics, they have gradually become an alternative chosen by some patients. Most of these drugs are mailed to China through cross-border medical services, overseas drug purchase platforms or third-party agencies, but patients are required to have relevant medical information, such as prescriptions, pathology reports, etc., to complete the drug deployment and customs clearance process.

When purchasing drugs overseas, patients must choose formal channels, especially avoid purchasing through uncertified personal agents or non-professional institutions to prevent the purchase of counterfeit or inferior drugs. At the same time, it is recommended to use this drug under the guidance of a doctor, and to regularly test blood sugar, liver and kidney function, and tumor-related indicators to ensure drug safety.

Reference materials:https://www.piqray.com/